Nationwide Children's Hospital chosen as a BCR for TCGA

Nationwide Children's Hospital recently was awarded an initial $5.5 million contract from the National Cancer Institute (NCI) to serve as a Biospecimen Core Resource (BCR) for The Cancer Genome Atlas (TCGA), a program co-managed by the NCI and the National Human Genome Research Institute (NHGRI), both part of the National Institutes of Health (NIH).

Following a three-year pilot phase, TCGA is moving forward to create a comprehensive catalog of the genomic changes involved in more than 20 common types of cancer. This large-scale effort is being carried out by a network of more than 100 researchers at organizations across the nation. The goal of TCGA is to further scientific understanding of the genomic changes in cancer, thereby improving the ability to diagnose, treat and prevent this disease. More information is available at http://cancergenome.nih.gov.

As a BCR for TCGA, The Research Institute at Nationwide Children's Hospital will be central to the process of acquiring both tumor and normal tissue samples and their accompanying clinical information from contributing medical and research centers. BCR functions include analyzing all specimens to ensure they meet rigorous quality standards for each tumor type and ensuring that the clinical information for each sample is available. Once the optimal specimens are examined and processed, the BCR distributes the DNA and RNA extracted from the specimens to researchers in the TCGA research network.

"Our selection as a key resource for The Cancer Genome Atlas is an honor and a significant validation of our existing expertise and national reputation for biospecimen banking and tissue processing," said John Barnard, MD, president of The Research Institute at Nationwide Children's.